Pharma TechOps 2017, pharma market access.#Pharma #market #access

Posted On Jan 17 2018 by

FROM A FIRE FIGHTER MENTALITY TO A FORMULA 1 SPIRIT November 30 December 01, 2017 | Maritim proArte Hotel Berlin, Germany The Pharma TechOps Sessions The 2.5-day event is a unique combination of Inspirational keynotes Panel discussions Well moderated, interactive World Caf sessions Challenge Your Peers roundtables Be part of our exclusive platform to explore various business models, case studies actions to increase profitability and identify missing gaps that hide opportunities business chances for your challenges. The 2.5-day event is a unique combination of Inspirational keynotes Panel discussions Well moderated, interactive World Caf sessions Challenge Your Peers roundtables Be part …


Indian pharmaceutical exports: The growth story, Business Standard, pharma market access.#Pharma #market #access

Posted On Jan 17 2018 by

Indian pharmaceutical exports: The growth story The Indian pharmaceutical industry is the largest supplier of cost effective generic medicines to the developed world. With the widest range of medicines available for exports and with the availability of the largest number of approved pharmaceutical manufacturing facilities, India is all set to become the leader of pharmaceutical exports to the world. According to IBEF, the domestic Indian pharmaceutical industry is estimated to be $ 26 billion in 2014 growing at nearly 20 percent and is expected to reach nearly $ 50 billion in 2020. . Key stories on business-standard.com are available to …


Mixed news for pharma on UK s Accelerated Access Review, pharma market access.#Pharma #market #access

Posted On Jan 17 2018 by

Mixed news for pharma on UK’s Accelerated Access Review New funding will go towards ASHNs, SME s and the Pathway Transformation Fund to name a few The UK government has announced it will make £86m available to smaller firms developing and testing new technologies in the NHS. The scheme is the first stage in the independent Accelerated Access Review (AAR) – designed to accelerate patient access to new medicines and devices in the UK – that was published last October. It set out a series of recommendations for streamlining the access process for new drugs, medical devices, diagnostics and digital …


Vanillin Market: Global Industry Analysis, Size and Forecast, 2015 to 2025, pharmaceutical market size.#Pharmaceutical #market #size

Posted On Jan 17 2018 by

Vanillin Market:Global Industry Analysis and Opportunity Assessment 2015-2025 Vanillin Market:Global Industry Analysis and Opportunity Assessment 2015-2025 REP-GB-483 January 2018 Status : Ongoing Category:Food and Beverages Vanillin is primarily used in the food and beverages industry to enhance the sweetness of food items such as chocolates, candy, biscuits, ice-creams and cakes. Vanillin is extracted from an extract of the vanilla bean, and it s considered to be an organic compound. Vanillin can be produced naturally or it can be chemically synthesized. The seed pods of vanilla planifolia is used to extract the natural vanillin. In order to extract the flavor of …


OWC Pharmaceutical Research Corp, pharmaceutical market research.#Pharmaceutical #market #research

Posted On Jan 13 2018 by

YahooFinance OWC Pharmaceutical Research Corp. Enters Into a Strategic Relationship With Germany-Based mediq Innovation Experts PETACH TIKVA, Israel, May 31, 2017 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OWCP) and mediq Innovation Partners (mediq) are pleased to announce an agreement for the introduction of OWCP’s active cannabinoid-based topical psoriasis cream to the German market. Frankfurt, Germany-based mediq has extensive experience, knowledge and a successful track record in enabling Israel-based companies to penetrate the European markets. mediq’s objectives for OWCP will consist of both scientific collaboration and most importantly the development of a commercial market for OWCP’s proprietary, active cannabinoid-based topical psoriasis …


Clarocision Research – Marketing, Focus Groups, Market Research, Surveys, US, pharmaceutical market research.#Pharmaceutical #market #research

Posted On Jan 13 2018 by

Clarocision Research Marketing Global Market Research Global Market Research Global Market Research Call +1 877-659-5468 Some of Our Clients: Some of Our Clients Clarocision Research Marketing provides fast accurate market research solutions across the US, Canada, Caribbean, Latin America. We exceed clients’ expectations with our: Focus Groups Panels in the US, Canada, Caribbean, Latin America Diverse Consumer Healthcare Panels Innovative Research Tools Processes Fully-Equipped Facilities Decades of Professional Moderating Experience What Our Clients Are Saying: “Clarocision was able to quickly & precisely identify our business needs and quickly draft a research solution with accurate findings and significant ROI.” Learn More …


Pharmaceutical Industry, Indian Pharma Industry, Pharmaceutical Industry, Pharma Industry Overview, pharmaceutical market share.#Pharmaceutical #market #share

Posted On Jan 12 2018 by

Indian Pharmaceutical Industry “The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent.” The Indian Pharmaceutical Industry today is in the front rank of India s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Playing a …


PMEA – Pharmaceutical Market Excellence Awards, pharmaceutical market.#Pharmaceutical #market

Posted On Jan 11 2018 by

pharmaceutical market PMEA rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. It reflects the dynamic healthcare environment and the industry’s development of new, intelligent ways to improve patient care and outcomes and provide greater value for healthcare providers and payers. Specifically designed to recognise and commend excellence, best practice and innovation in local, European and international markets, the programme includes three new categories for 2017: PMEA 2017 aims to… 1. Recognise work that delivers clearly identifiable benefits and improved outcomes for patients. 2. Recognise the value of responsible business practice that improve: Standards …


Pharmaceutical Pricing Policies in a Global Market, pharmaceutical market access.#Pharmaceutical #market #access

Posted On Jan 10 2018 by

Directorate for Employment, Labour and Social Affairs Publication date: September 2008 215 pages, 9 tables, 36 graphs Released on Wednesday, 24 September 2008 OECD Health Policy Studies Pharmaceutical Pricing Policies in a Global Market Directorate for Employment, Labour and Social Affairs, Health Division Pharmaceutical pricing policies are designed with national objectives in mind, but are the transnational implications always taken into account? This publication presents an analysis of comparative price levels, making use of a unique dataset to construct the most comprehensive pan-OECD pharmaceutical price index to date. It also draws upon original case studies of pharmaceutical pricing and reimbursement …


Pharmaceutical Pricing Policies in a Global Market, pharmaceutical market access.#Pharmaceutical #market #access

Posted On Jan 10 2018 by

Health policies and data 24/09/2008 – OECD s Pharmaceutical Pricing Policies in a Global Market details national differences in the consumption and cost of medicines and outlines how prices are established, exploring the advantages and disadvantages of various policies and practices. Pharmaceutical spending varies across countries The report shows that pharmaceutical spending, on average across OECD countries, was $401 (USD PPP) per person in 2005, with half of OECD countries spending within 20% of the average. The U.S. spent the most at $792 per capita and Mexico the least at $144. While richer countries tend to spend more per person …